← FDA DRUG APPROVALS

FDA ANDA · ANDA204327

PARICALCITOL

Sponsor: AMNEAL PHARMS

APPLICATION
ANDA204327
TYPE
ANDA
ORIGINAL APPROVAL
2016-01-13
LATEST ACTION
2016-01-13
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

PARICALCITOLPrescription
PARICALCITOL 1MCG · CAPSULE · ORAL
PARICALCITOLPrescription
PARICALCITOL 2MCG · CAPSULE · ORAL
PARICALCITOLPrescription
PARICALCITOL 4MCG · CAPSULE · ORAL

Approval history

2016-01-13UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →